insulin glargine,human recombinant analog/lixisenatide

100 unit-33 mcg/mL (3 mL) — Pen Injector

DIABETES NON-INSULIN

Also known as: SOLIQUA 100-33

Coverage by Insurer

Informational only — Coverage rules change frequently; verify tier placement and restrictions with your plan or pharmacy before acting.
Source: Excel (XLSX)  ·  Formulary date: Jan 5, 2026  ·  Checked: 19 hours, 17 minutes ago
Plan Tier Prior Auth Step Therapy Quantity Limit Restrictions
TRICARE Uniform Formulary 2026 Tier 3 - Non-Formulary PA
Something not right?